[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Macitentan Market Report 2016

November 2016 | 99 pages | ID: U97ABD50FC8EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Macitentan

Revenue, means the sales value of Macitentan

This report studies sales (consumption) of Macitentan in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Pfizer, Inc. (US)
  • Bayer HealthCare Pharmaceuticals (Germany)
  • GlaxoSmithKline Plc (UK)
  • Eli Lilly and Company (US)
  • Gilead Sciences, Inc. (US)
  • Sanofi S.A (France)
  • Nippon Shinyaku Co., Ltd. (Japan)
  • United Therapeutics Corp. (US)
  • Cipla Limited (India)
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Macitentan in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
United States Macitentan Market Report 2016

1 MACITENTAN OVERVIEW

1.1 Product Overview and Scope of Macitentan
1.2 Classification of Macitentan
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Macitentan
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Macitentan (2011-2021)
  1.4.1 United States Macitentan Sales and Growth Rate (2011-2021)
  1.4.2 United States Macitentan Revenue and Growth Rate (2011-2021)

2 UNITED STATES MACITENTAN COMPETITION BY MANUFACTURERS

2.1 United States Macitentan Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Macitentan Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Macitentan Average Price by Manufactures (2015 and 2016)
2.4 Macitentan Market Competitive Situation and Trends
  2.4.1 Macitentan Market Concentration Rate
  2.4.2 Macitentan Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES MACITENTAN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Macitentan Sales and Market Share by Type (2011-2016)
3.2 United States Macitentan Revenue and Market Share by Type (2011-2016)
3.3 United States Macitentan Price by Type (2011-2016)
3.4 United States Macitentan Sales Growth Rate by Type (2011-2016)

4 UNITED STATES MACITENTAN SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Macitentan Sales and Market Share by Application (2011-2016)
4.2 United States Macitentan Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES MACITENTAN MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Macitentan Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Macitentan Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bayer HealthCare Pharmaceuticals (Germany)
  5.2.2 Macitentan Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bayer HealthCare Pharmaceuticals (Germany) Macitentan Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc (UK)
  5.3.2 Macitentan Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Plc (UK) Macitentan Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Eli Lilly and Company (US)
  5.4.2 Macitentan Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Eli Lilly and Company (US) Macitentan Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Gilead Sciences, Inc. (US)
  5.5.2 Macitentan Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Gilead Sciences, Inc. (US) Macitentan Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Sanofi S.A (France)
  5.6.2 Macitentan Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Sanofi S.A (France) Macitentan Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Nippon Shinyaku Co., Ltd. (Japan)
  5.7.2 Macitentan Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Nippon Shinyaku Co., Ltd. (Japan) Macitentan Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 United Therapeutics Corp. (US)
  5.8.2 Macitentan Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 United Therapeutics Corp. (US) Macitentan Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Cipla Limited (India)
  5.9.2 Macitentan Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Cipla Limited (India) Macitentan Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview

6 MACITENTAN MANUFACTURING COST ANALYSIS

6.1 Macitentan Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Macitentan

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Macitentan Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Macitentan Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES MACITENTAN MARKET FORECAST (2016-2021)

10.1 United States Macitentan Sales, Revenue Forecast (2016-2021)
10.2 United States Macitentan Sales Forecast by Type (2016-2021)
10.3 United States Macitentan Sales Forecast by Application (2016-2021)
10.4 Macitentan Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Macitentan
Table Classification of Macitentan
Figure United States Sales Market Share of Macitentan by Type in 2015
Table Application of Macitentan
Figure United States Sales Market Share of Macitentan by Application in 2015
Figure United States Macitentan Sales and Growth Rate (2011-2021)
Figure United States Macitentan Revenue and Growth Rate (2011-2021)
Table United States Macitentan Sales of Key Manufacturers (2015 and 2016)
Table United States Macitentan Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Macitentan Sales Share by Manufacturers
Figure 2016 Macitentan Sales Share by Manufacturers
Table United States Macitentan Revenue by Manufacturers (2015 and 2016)
Table United States Macitentan Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Macitentan Revenue Share by Manufacturers
Table 2016 United States Macitentan Revenue Share by Manufacturers
Table United States Market Macitentan Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Macitentan Average Price of Key Manufacturers in 2015
Figure Macitentan Market Share of Top 3 Manufacturers
Figure Macitentan Market Share of Top 5 Manufacturers
Table United States Macitentan Sales by Type (2011-2016)
Table United States Macitentan Sales Share by Type (2011-2016)
Figure United States Macitentan Sales Market Share by Type in 2015
Table United States Macitentan Revenue and Market Share by Type (2011-2016)
Table United States Macitentan Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Macitentan by Type (2011-2016)
Table United States Macitentan Price by Type (2011-2016)
Figure United States Macitentan Sales Growth Rate by Type (2011-2016)
Table United States Macitentan Sales by Application (2011-2016)
Table United States Macitentan Sales Market Share by Application (2011-2016)
Figure United States Macitentan Sales Market Share by Application in 2015
Table United States Macitentan Sales Growth Rate by Application (2011-2016)
Figure United States Macitentan Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Macitentan Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Macitentan Sales Market Share (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Basic Information List
Table Bayer HealthCare Pharmaceuticals (Germany) Macitentan Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Macitentan Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Macitentan Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) Macitentan Sales Market Share (2011-2016)
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) Macitentan Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company (US) Macitentan Sales Market Share (2011-2016)
Table Gilead Sciences, Inc. (US) Basic Information List
Table Gilead Sciences, Inc. (US) Macitentan Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gilead Sciences, Inc. (US) Macitentan Sales Market Share (2011-2016)
Table Sanofi S.A (France) Basic Information List
Table Sanofi S.A (France) Macitentan Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A (France) Macitentan Sales Market Share (2011-2016)
Table Nippon Shinyaku Co., Ltd. (Japan) Basic Information List
Table Nippon Shinyaku Co., Ltd. (Japan) Macitentan Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nippon Shinyaku Co., Ltd. (Japan) Macitentan Sales Market Share (2011-2016)
Table United Therapeutics Corp. (US) Basic Information List
Table United Therapeutics Corp. (US) Macitentan Sales, Revenue, Price and Gross Margin (2011-2016)
Table United Therapeutics Corp. (US) Macitentan Sales Market Share (2011-2016)
Table Cipla Limited (India) Basic Information List
Table Cipla Limited (India) Macitentan Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cipla Limited (India) Macitentan Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Macitentan
Figure Manufacturing Process Analysis of Macitentan
Figure Macitentan Industrial Chain Analysis
Table Raw Materials Sources of Macitentan Major Manufacturers in 2015
Table Major Buyers of Macitentan
Table Distributors/Traders List
Figure United States Macitentan Production and Growth Rate Forecast (2016-2021)
Figure United States Macitentan Revenue and Growth Rate Forecast (2016-2021)
Table United States Macitentan Production Forecast by Type (2016-2021)
Table United States Macitentan Consumption Forecast by Application (2016-2021)


More Publications